Mixed Model Repeated Measures News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Mixed model repeated measures. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Mixed Model Repeated Measures Today - Breaking & Trending Today

Supernus Announces Positive Results from Phase III Study for SPN-812 in Adults with ADHD – IT Business Net


Met primary endpoint with robust statistical significance
Showed efficacy on both hyperactivity/impulsivity and inattention subscales with statistical significance
Showed statistically significant onset of action as early as week 2
Had a good safety and tolerability profile throughout the study
Topline data confirm positive results from prior Phase IIa study in adults and Phase III studies of SPN-812 in children and adolescents
ROCKVILLE, Md., Dec. 22, 2020 (GLOBE NEWSWIRE) Supernus Pharmaceuticals, Inc. (Nasdaq: SUPN), a pharmaceutical company focused on developing and commercializing products for the treatment of central nervous system diseases, today announced positive topline results from a Phase III study of SPN-812 in adults (P306) for the treatment of attention deficit hyperactivity disorder (ADHD). ....

Jack Khattar , Jacka Khattar , Jim Kelly , Peter Vozzo , Exchange Commission , Securities Exchange , Drug Administration , Supernus Pharmaceuticals Inc , Supernus Pharmaceuticals , Symptom Rating Scale , Clinical Global Impression , Complete Response Letter , New Drug Application , Chief Executive Officer , Mixed Model Repeated Measures , Full Analysis Set , Investor Relations , Prescribing Information , Looking Statements , Private Securities Litigation Reform Act , Securities Exchange Act , Executive Vice President , பலா காட்டார் , ஜாக்கா காட்டார் , ஜிம் கெல்லி , பரிமாற்றம் தரகு ,